ArticleMaterials today. Bio2026

Renal-targeted tFNA-TPP nanoagonist treats acute kidney injury by amplifying mitophagy.

Jinguo Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.